The Summary of Product Characteristics (SmPC) is the legally binding summary of a medicinal product’s features for healthcare professionals. It is part of the approved product information and describes, among other things, therapeutic indications, dosage, contraindications, warnings, and side effects. The QRD template provides a formal textual framework for this, with predefined headings and standard phrasing. <\/p>\n
The Summary of Product Characteristics, known in the European context as the SmPC, translates officially assessed data into a structured document for prescription, dispensing, and use. Article 11 of Directive 2001\/83\/EC dictates the order and core of the required information. Its content is not freely designable: it is approved with the marketing authorization and must be updated according to relevant findings or regulatory decisions. <\/p>\n
For centrally authorized medicinal products, the SmPC appears as Annex I of the product information. Further annexes contain conditions and requirements, as well as labeling and the package leaflet. Thus, the SmPC is a central reference point for benefit-risk communication and safe use, not merely a technical product description. <\/p>\n
QRD stands for Quality Review of Documents. The QRD template provided by the EMA organizes the SmPC, labeling, and package leaflet into a uniform structure. It contains headings, instructions for use, and applicable standard texts. Placeholders and selection texts indicate which details are to be inserted, selected, or deleted on a product-specific basis. <\/p>\n
The template does not decide on the scientific justification of a text and does not replace a legal review. Applicants remain responsible for ensuring that the product information meets all relevant requirements. Deviations from applicable standard phrasing or an unusual structure require a comprehensible product-specific justification and are subject to regulatory assessment. <\/p>\n
The SmPC also serves as a reference for many other regulated texts. It must be consistent in content with the labeling and the package leaflet, even though individual pieces of information are presented differently to suit the target audience. The QRD structure helps in locating the corresponding sections and managing translations in the official languages uniformly. However, it does not automatically prevent contradictions: every change must be checked for its impact on all parts of the product information. <\/p>\n
During the authorization process, the product information is developed iteratively. Clinical, non-clinical, and pharmaceutical assessors can suggest text changes; the final agreed version is what is authorized. The SmPC and QRD template thus combine scientific evidence, mandatory legal information, and practical usability. Standardization is intended to promote clarity and consistency without obscuring product-specific risks, restrictions, or conditions of use. <\/p>\n
For editorial work, the separation of content and form is essential. The QRD template organizes information and provides applicable standard phrasing, while the SmPC contains the product-specific, scientifically justified statement. If new findings are approved, all linked parts of the product information must be reviewed. This ensures that healthcare professionals and patients remain informed with different but consistent texts. <\/p>\n
Clean version control is indispensable in this process. Only a clearly authorized version prevents outdated instructions, dosages, or warnings from persisting in downstream materials. <\/p>\n
Responsible approval and documentation of every change ensures traceability.<\/p>\n
This ensures that the product information remains a controlled, uniform, and technically robust component of medicinal product communication even after authorization.<\/p>\n
The package leaflet is aimed at patients and explains safe use in understandable language. In contrast, the SmPC is aimed at doctors, pharmacists, and other healthcare professionals. Both texts are based on the same authorization decision but differ in target audience, level of detail, and presentation style. <\/p>\n
Labeling is also a distinct part of the product information. It concerns the information on the container and outer packaging. The existing related entries for “labeling” and “labelling” describe this level of marking; they are not synonymous with the SmPC or the QRD template. The QRD template encompasses the formal interaction of the three parts of the product information but does not replace any of them. <\/p>\n
Clinical data directly influence the subsequent SmPC: endpoints, safety profile, populations, dosages, and instructions for use must be reliably derivable from the study documents. Therefore, it should already be clear during development which statements the data support and which formulations must not be anticipated in a later product information. Particular care is required for consistency between the protocol, investigator’s brochure, safety information, and drafts of the authorization documents. <\/p>\n
Full-service CROs like Mediconomics provide support in planning data relevant to product information, checking the consistency of study documents, and creating regulatory text drafts. Specific services include medical writing, safety writing, data review, change coordination, and the collaboration of clinical development, pharmacovigilance, and regulatory affairs. <\/p>\n
Is the SmPC advertising?<\/strong><\/p>\n No. It is part of the authorization and contains legally binding technical information for the safe and effective use of the medicinal product. <\/p>\n Does the QRD template only apply to the SmPC?<\/strong><\/p>\n No. The QRD product information template includes the SmPC, further annexes, labeling, and the package leaflet for centrally authorized medicinal products. <\/p>\n Is a company allowed to deviate from QRD standard texts?<\/strong><\/p>\n The product information must be product-specifically accurate and comply with the legal framework. Deviations from applicable standard texts are assessed during the authorization process. <\/p>\n The Summary of Product Characteristics (SmPC) is the legally binding summary of a medicinal product’s features for healthcare professionals. It is part of the approved product information and describes, among other things, therapeutic indications, dosage, contraindications, warnings, and side effects. The QRD template provides a formal textual framework for this, with predefined headings and standard […]<\/p>\n","protected":false},"author":10,"featured_media":0,"parent":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"glossary-cat":[20],"class_list":["post-7819","glossary","type-glossary","status-publish","hentry","glossary-cat-regulatory-affairs-zulassung"],"acf":[],"related_terms":"","external_url":"","internal_reference_id":"","_links":{"self":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/7819","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary"}],"about":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/types\/glossary"}],"author":[{"embeddable":true,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/users\/10"}],"version-history":[{"count":0,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/7819\/revisions"}],"wp:attachment":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/media?parent=7819"}],"wp:term":[{"taxonomy":"glossary-cat","embeddable":true,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary-cat?post=7819"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Regulatory References<\/h2>\n
\n